About
Technology
Issues
FAQ
Links
Official Page
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.